ReviewMolecules (Basel, Switzerland)2026
Hydrodynamic Cavitation in Juice Processing: Linking PME, PPO, and POD Responses to Physicochemical Stability and Quality Retention.
Review in Molecules (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hydrodynamic cavitation (HC) is increasingly investigated for juice processing, but changes in pectin methylesterase (PME), polyphenol oxidase (PPO), and peroxidase (POD) activity do not by themselves establish a technological benefit. Several mild or temperature-limited conditions left substantial residual activity, whereas stronger control was observed in thermally assisted, more severe, or hurdle-assisted treatments. Physical stability can nevertheless improve despite limited PME or PPO inactivation, consistent with concurrent particle-size reduction, pectin restructuring, rheological modification, and other matrix-level changes. Within-study quantitative comparisons showed that, in all six directly comparable enzyme-level contrasts, inactivation at the selected or experimentally validated condition was lower than the largest directly observed value for the same enzyme. In the three exact same-condition PPO storage trajectories, end-of-storage inactivation was lower than at day 0. Current evidence therefore supports treatment-level responses more strongly than cavitation-specific causality and does not justify a universal HC operating window. Technologically meaningful process development requires matrix-, enzyme-, and reactor-specific conditions that provide sufficient enzyme control for a defined product function, a favorable linked physicochemical response, acceptable quality retention, and persistence during storage, supported by adequate hydraulic and thermal characterization and controls matched to the causal claim.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.